World
Russia’s Covid Vaccine Shows Potential in Peer Review, Lancet Reports
- Shot produces antibody response, no adverse effects: Lancet
- Publication is first time Russia data has been peer-reviewed
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Russia’s proposed Covid-19 vaccine induced an antibody response in all participants in early trials and found no serious adverse effects, according to the first vetted data on the controversial project.